Nicole A. Cipriani, MD, offers guidance for community oncologists regarding the role of BRAF p.V600E testing in patients with papillary thyroid carcinoma.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Aggressive Digital Papillary Adenocarcinoma (ADPA) is a rare malignant neoplasm arising from eccrine sweat glands, most commonly affecting the digits, including fingers and toes. Clinically, the ...

Heterogeneous Hippo pathway (YAP/TAZ) activation in lung adenocarcinoma drives tumor progression by enabling ferroptosis ...

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...

Thousands of students and teachers in Philadelphia are being put at risk of cancer in classrooms, an investigation has found.

The authors present a histologic and immunohistochemical study of a case of primary thymic adenocarcinoma, an exceedingly rare cancer for which there is little genetic data.

With EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.